TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $133,000 | -63.6% | 12,419 | -50.0% | 0.02% | -66.2% |
| Q4 2020 | $365,000 | -83.2% | 24,839 | -83.1% | 0.07% | -90.4% |
| Q3 2016 | $2,167,000 | +838.1% | 146,633 | +486.5% | 0.77% | +650.5% |
| Q1 2016 | $231,000 | -96.2% | 25,000 | -94.7% | 0.10% | -96.0% |
| Q4 2015 | $6,003,000 | -2.7% | 476,069 | -0.5% | 2.59% | +0.4% |
| Q3 2015 | $6,169,000 | -44.0% | 478,569 | -5.2% | 2.58% | -28.1% |
| Q2 2015 | $11,010,000 | +549.2% | 504,562 | +502.0% | 3.59% | +481.7% |
| Q1 2015 | $1,696,000 | – | 83,820 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |